Abreva and Application site scab - a phase IV clinical study of FDA data
Application site scab is found among people who take Abreva, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Abreva and have Application site scab. It is created by eHealthMe based on reports of 16,308 people who have side effects when taking Abreva from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
16,308 people reported to have side effects when taking Abreva.
Among them, 172 people (1.05%) have Application site scab.
What is Abreva?
Abreva has active ingredients of docosanol. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 16,320 Abreva users for its effectiveness, alternative drugs and more.
What is Application site scab?
Application site scab (hard coating on the skin formed at application site) is found to be associated with 369 drugs and 256 conditions by eHealthMe.
Number of Abreva and Application site scab reports submitted per year:
Time on Abreva when people have Application site scab *:
Gender of people who have Application site scab when taking Abreva*:
Age of people who have Application site scab when taking Abreva *:
Common drugs people take besides Abreva *:
Common side effects people have besides Application site scab *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Abreva and have Application site scab?Check whether Application site scab is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Application site scab and when was it recovered:
Expand to all the drugs that have ingredients of docosanol:
Alternative drugs to, pros and cons of Abreva:
- Abreva (16,320 reports)
Common Abreva side effects:
Browse all side effects of Abreva:a b c d e f g h i j k l m n o p q r s t u v w x y z
Application site scab treatments and more:
- Application site scab (2,042 reports)
COVID vaccines that are related to Application site scab:
- Application site scab in Moderna COVID Vaccine
- Application site scab in Pfizer BioNTech Covid Vaccine
- Application site scab in Johnson and Johnson Covid Vaccine
Common drugs associated with Application site scab:
All the drugs that are associated with Application site scab:
- Application site scab (369 drugs)
Common conditions associated with Application site scab:
- Actinic keratosis: 508 reports
- Hair loss: 144 reports
- Keratosis - actinic (solar): 506 reports
- Oral herpes: 150 reports
- Pain: 126 reports
- Solar keratosis: 506 reports
All the conditions that are associated with Application site scab:
- Application site scab (256 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on docosanol (the active ingredients of Abreva) and Abreva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hypogammaglobulinaemia and Itching - 6 seconds ago
- Synthroid and Sinus Arrhythmia - 11 seconds ago
- Zoladex and X-Ray Abnormal - 17 seconds ago
- Peginterferon and Nosebleed - 28 seconds ago
- Rabeprazole and Hypocalcaemia - 34 seconds ago
- Cranberry and Oxycontin drug interaction - 48 seconds ago
- Zocor and Malnutrition - 57 seconds ago
- Cortef and Radiculopathy - a minute ago
- Calcium Ascorbate and Plavix drug interaction - a minute ago
- Lasix and Hypoaesthesia - a minute ago